NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

from The NRG Oncology Podcast · host NRG Oncology

Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.

Episode metadata supplied by the publisher feed · Published Mar 11, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

NRG-GU012, the SAMURAI Study, with Dr. William A. Hall

0:00 34:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The NRG Oncology Podcast?

This episode is 34 minutes long.

When was this The NRG Oncology Podcast episode published?

This episode was published on March 11, 2025.

Can I download this The NRG Oncology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!